Interleukin-1 Receptor-Associated Kinase 4 Is Essential for Initial Host Control of Brucella abortus Infection

被引:24
|
作者
Oliveira, Fernanda S. [1 ]
Carvalho, Natalia B. [1 ]
Brandao, Ana Paula M. S. [1 ]
Gomes, Marco Tulio R. [1 ]
de Almeida, Leonardo A. [1 ]
Oliveira, Sergio C. [1 ]
机构
[1] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Inst Biol Sci, BR-31270901 Belo Horizonte, MG, Brazil
关键词
TOLL-LIKE RECEPTOR-4; KAPPA-B ACTIVATION; BACTERIAL-INFECTIONS; IMMUNE-RESPONSES; IRAK FAMILY; DENDRITIC CELLS; MICE; INNATE; MEMBER; GAMMA;
D O I
10.1128/IAI.05289-11
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Brucella abortus is a facultative intracellular bacterial pathogen that causes abortion in domestic animals and undulant fever in humans. Recent studies have revealed that Toll-like receptor (TLR)-initiated immune response to Brucella spp. depends on myeloid differentiation factor 88 (MyD88) signaling. Therefore, we decided to study the role of the interleukin-1 receptor-associated kinase 4 (IRAK-4) in host innate immune response against B. abortus. After Brucella infection, it was shown that the number of CFU in IRAK-4(-/-) mice was high compared to that in IRAK-4(-/-) animals only at 1 week postinfection. At 3 and 6 weeks postinfection, IRAK-4(-/-) mice were able to control the infection similarly to heterozygous animals. Furthermore, the type 1 cytokine profile was evaluated. IRAK-4(-/-) mice showed lower production of systemic interleukin-12 (IL-12) and gamma interferon (IFN-gamma). Additionally, a reduced percentage of CD4(+) and CD8(+) T cells expressing IFN-gamma was observed compared to IRAK-4(-/-). Further, the production of IL-12 and tumor necrosis factor alpha (TNF-alpha) by macrophages and dendritic cells from IRAK-4(-/-) mice was abolished at 24 h after stimulation with B. abortus. To investigate the role of IRAK-4 in mitogen-activated protein kinase (MAPK) and NF-kappa B signaling pathways, macrophages were stimulated with B. abortus, and the signaling components were analyzed by protein phosphorylation. Extracellular signal-regulated kinase 1 (ERK1) and ERK2 and p38 as well as p65 NF-kappa B phosphorylation was profoundly impaired in IRAK-4(-/-) and MyD88(-/-) macrophages activated by Brucella. In summary, the results shown in this study demonstrated that IRAK-4 is critical to trigger the initial immune response against B. abortus but not at later phases of infection.
引用
收藏
页码:4688 / 4695
页数:8
相关论文
共 50 条
  • [21] Activation of interleukin-1 receptor-associated kinase by gram-negative flagellin
    Moors, MA
    Li, LW
    Mizel, SB
    INFECTION AND IMMUNITY, 2001, 69 (07) : 4424 - 4429
  • [22] The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation
    Yamin, TT
    Miller, DK
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (34) : 21540 - 21547
  • [23] ROLE OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 1 IN ENDOTHELIAL CELLS INJURY AND REPAIR
    Miao, Jiaxing
    Zhao, Jing
    Zhao, Yutong
    Baoyinna, Baoyinna
    Shaheen, Nargis
    Kasey, Lee
    Xi, Xiaoqing
    Xia, Boyu
    JOURNAL OF INVESTIGATIVE MEDICINE, 2024, 72 (07) : 142 - 145
  • [24] Interleukin-1 receptor-associated kinase 1 correlates with metastasis and invasion in endometrial carcinoma
    Wang, Yilin
    Wang, Yanyan
    Duan, Xianzhi
    Wang, Yinuo
    Zhang, Zhenyu
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (03) : 2545 - 2555
  • [25] Conformational flexibility and inhibitor binding to unphosphorylated interleukin-1 receptor-associated kinase 4 (IRAK4)
    Wang, Li
    Ferrao, Ryan
    Li, Qiubai
    Hatcher, John M.
    Choi, Hwan Geun
    Buhrlage, Sara J.
    Gray, Nathanael S.
    Wu, Hao
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (12) : 4511 - 4519
  • [26] Deficiency in Interleukin-1 receptor-associated kinase (IRAK) 4 activity attenuates manifestations of murine Lupus
    Medvedev, Andrei
    Manavalan, Tissa
    Pattabiraman, Gouthann
    Murphy, Michael Bradford
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [27] Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy
    Kelly, Priscilla N.
    Romero, Donna L.
    Yang, Yibin
    Shaffer, Arthur L., III
    Chaudhary, Divya
    Robinson, Shaughnessy
    Miao, Wenyan
    Rui, Lixin
    Westlin, William F.
    Kapeller, Rosana
    Staudt, Louis M.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2015, 212 (13): : 2189 - 2201
  • [28] Highly potent and selective interleukin-1 receptor-associated kinase 4 inhibitors for the therapy of lymphoid malignancies
    Kelly, Priscilla N.
    Chaudhary, Divya
    Young, Ryan M.
    Shaffer, Art
    Robinson, Shaughnessy
    Romero, Donna L.
    Kapeller, Rosana
    Staudt, Louis M.
    CANCER RESEARCH, 2014, 74 (19)
  • [29] Case Report: Extensive Phosphorylation of Interleukin-1 Receptor-Associated Kinase 4 in a Patient With Schnitzler Syndrome
    Hodl, Isabel
    Bosch, Philipp
    Dreo, Barbara
    Stradner, Martin H.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [30] SCREENING OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4 DEFICIENCY IN PATIENTS WITH HISTORY OF SEVERE PNEUMOCOCCAL INFECTIONS
    Yoshikawa, H.
    Watanabe, S.
    Takada, H.
    PEDIATRIC RESEARCH, 2010, 68 : 433 - 433